comprehensive -WSS

comprehensive

author：focus 2025-10-02 19:21:04 - browse：95

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Dark money group runs ads on China biotech bill

hotspot

WSS

Childbirth

Addiction doctors spar with methadone clinics over legislation

Finland to offer bird flu vaccine to select groups of people, a possible global first

Eli Lilly’s Zepbound improved liver scarring in mid

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

The most pressing bird flu mysteries scientists want answered

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

Supreme Court strikes down use of affirmative action

FDA approves Moderna’s RSV vaccine, its second licensed product

In age of alternative facts, a scholarly course on calling out crap

Finland to offer bird flu vaccine to select groups of people, a possible global first

State Dept. review finds Biden bears some blame for Afghanistan failures

Adam's Biotech Scorecard: Do Sarepta's exon

Malaria cases in Florida and Texas: Here’s what you need to know

Lab trade group sues FDA to halt regulation of lab

How one medical school became remarkably diverse

Eli Lilly’s Zepbound improved liver scarring in mid

entertainment

Average age of first period drops to 11.9 years, study shows

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Focused ultrasound for uterine fibroids: an uphill battle

Medicare Advantage's lean provider networks lead CMS complaints

What will save rural psychiatry services? Higher Medicaid payments

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

focus

hotspot

hotspot

leisure time